<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01305720</url>
  </required_header>
  <id_info>
    <org_study_id>734</org_study_id>
    <nct_id>NCT01305720</nct_id>
  </id_info>
  <brief_title>The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants</brief_title>
  <official_title>The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Near infrared spectroscopy offers the possibility of noninvasive and continuous bedside
      investigation of cerebral and mesenteric oxygenation in newborn infants. Using this technique
      the investigators investigated the effect of mydriatic eye drops on cerebral and mesenteric
      oxygenation in preterm infants
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cerebral and mesenteric oxygenation will be measured by NIRS before, during and after the
      mydriatic eye drops are instilled.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Effect of Mydriatic Eye Drops on Cerebral and mesenteric Oxygenation</measure>
    <time_frame>one year</time_frame>
    <description>By NIRS cerebral and mesenteric oxygenation will be measured before, during and after mydriatic eye drops are instilled.</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Prematurity of Fetus</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>near infrared spectroscopy: invos 5100</intervention_name>
    <description>NIRS device used in this study, the optical field includes a volume of tissue approximately 2 cm deep to the surface probe with a 4-mm source-detector distance, and thus, organ-specific monitoring is feasible in small patients. With informed consent, the investigators applied NIRS probes to the forehead and abdomen for cerebral (rSO2C) and abdominal (rSO2P) regional oxygen saturation measurements.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. &lt; 32 gestational age and/or &lt; 1500gr.

          2. â‰¥ 28th day preterm infants

          3. Instilled mydriatic eye drops for ROP examination

        Exclusion Criteria:

          1. Sepsis

          2. Shock

          3. Severe intracranial hemorrhage

          4. NEC

          5. Abdominal and cranial surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hatice Tatar Aksoy, MD</last_name>
    <phone>0905327114054</phone>
    <email>haticetatar@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ugur Dilmen, Prof.</last_name>
    <phone>0903123065270</phone>
    <email>ugurdilmen@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity and Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hatice Tatar Aksoy, MD</last_name>
      <phone>0905327114054</phone>
      <email>haticetatar@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Hatice Tatar Aksoy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2011</study_first_submitted>
  <study_first_submitted_qc>February 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2011</study_first_posted>
  <last_update_submitted>February 28, 2011</last_update_submitted>
  <last_update_submitted_qc>February 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2011</last_update_posted>
  <responsible_party>
    <name_title>Zekai Tahir Burak Maternity and Teaching Hospital</name_title>
    <organization>Zekai Tahir Burak Maternity and Teaching Hospital</organization>
  </responsible_party>
  <keyword>mydriatic</keyword>
  <keyword>NIRS</keyword>
  <keyword>preterm</keyword>
  <keyword>eye drops</keyword>
  <keyword>cerebral</keyword>
  <keyword>mesenteric oxygenation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Mydriatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

